{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:27:17Z","timestamp":1793608037123,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bbi.2026.106796","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T22:54:47Z","timestamp":1777762487000},"page":"106796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Reduced dementia risk in middle-aged and older atopic dermatitis patients treated with dupilumab: A target trial emulation"],"prefix":"10.1016","volume":"136","author":[{"given":"Yi-Hsuan","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Sheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng-Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2026.106796_b0005","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjd.19580","article-title":"The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990\u20132017","volume":"184","author":"Laughter","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bbi.2026.106796_b0010","doi-asserted-by":"crossref","first-page":"354","DOI":"10.7326\/M18-2246","article-title":"Prevalence of atopic eczema among patients seen in primary care: data from the health improvement network","volume":"170","author":"Abuabara","year":"2019","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbi.2026.106796_b0015","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.anai.2021.03.001","article-title":"Atopic dermatitis and dementia risk: a nationwide longitudinal study","volume":"127","author":"Pan","year":"2021","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.bbi.2026.106796_b0020","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jaad.2022.03.049","article-title":"Adult atopic eczema and the risk of dementia: a population-based cohort study","volume":"87","author":"Magyari","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bbi.2026.106796_b0025","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v103.4557","article-title":"Increased risk of Dementia in patients with Atopic Dermatitis: a Nationwide Population-based Cohort Study","volume":"103","author":"Woo","year":"2023","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.bbi.2026.106796_b0030","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/ana.26506","article-title":"Allergic Diseases and risk of Incident Dementia and Alzheimer's Disease","volume":"93","author":"Joh","year":"2023","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbi.2026.106796_b0035","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaad.2024.05.029","article-title":"Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus conventional immunomodulatory therapy: a population-based cohort study","volume":"91","author":"Lin","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bbi.2026.106796_b0040","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/jdv.17094","article-title":"Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study","volume":"35","author":"Patruno","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.bbi.2026.106796_b0045","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1097\/DER.0000000000000686","article-title":"Dupilumab in elderly patients with Severe Atopic Dermatitis","volume":"32","author":"Russo","year":"2021","journal-title":"Dermatitis"},{"key":"10.1016\/j.bbi.2026.106796_b0050","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3390\/ijms20081927","article-title":"Interleukin-4 and Interleukin-13 Exacerbate Neurotoxicity of Prothrombin Kringle-2 in Cortex In Vivo via Oxidative stress","volume":"20","author":"Jeong","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2026.106796_b0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40478-025-01968-3","article-title":"Antagonizing Il10 and Il4 signaling via intracerebral decoy receptor expression attenuates A\u03b2 accumulation","volume":"13","author":"Koller","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbi.2026.106796_b0060","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1056\/NEJMp2407586","article-title":"\u201cTarget Trial Emulation\u201d for Observational Studies - potential and pitfalls","volume":"391","author":"Hubbard","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2026.106796_b0065","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S2215-0366(21)00084-5","article-title":"6-month neurological and psychiatric outcomes in 236\u2009379 survivors of COVID-19: a retrospective cohort study using electronic health records","volume":"8","author":"Taquet","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bbi.2026.106796_b0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2017.96","article-title":"A clinicopathological approach to the diagnosis of dementia","volume":"13","author":"Elahi","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbi.2026.106796_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004591","article-title":"Cardiovascular disease risk in patients with psoriasis receiving biologics targeting TNF-\u03b1, IL-12\/23, IL-17, and IL-23: a population-based retrospective cohort study","volume":"22","author":"Lin","year":"2025","journal-title":"PLoS Med."},{"key":"10.1016\/j.bbi.2026.106796_b0080","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jamadermatol.2025.1578","article-title":"Psoriasis Risk in patients with Atopic Dermatitis Treated with Dupilumab","volume":"161","author":"Lin","year":"2025","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.bbi.2026.106796_b0085","doi-asserted-by":"crossref","unstructured":"Lin TL, Fan YH, Fan KS, Juan CK, Chen YJ, Wu CY. Dupilumab impact on psychiatric and sleep disorder risk reduction in atopic dermatitis: A population-based cohort study. Ann Allergy Asthma Immunol. 2025;134:333-40.e6.","DOI":"10.1016\/j.anai.2024.11.016"},{"key":"10.1016\/j.bbi.2026.106796_b0090","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/EDE.0000000000000864","article-title":"Web Site and R Package for Computing E-values","volume":"29","author":"Mathur","year":"2018","journal-title":"Epidemiology"},{"key":"10.1016\/j.bbi.2026.106796_b0095","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity Analysis in Observational Research: introducing the E-Value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbi.2026.106796_b0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neulet.2014.01.019","article-title":"Association of interleukin-4 genetic polymorphisms with sporadic Alzheimer's disease in Chinese Han population","volume":"563","author":"Li","year":"2014","journal-title":"Neurosci. Lett."},{"issue":"9","key":"10.1016\/j.bbi.2026.106796_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044260","article-title":"Plasma based markers of [11C] PiB-PET brain amyloid burden","volume":"7","author":"Kiddle","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbi.2026.106796_b0110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12974-023-02789-8","article-title":"Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer's disease but not Lewy body dementias","volume":"20","author":"Chai","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2026.106796_b0115","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni.3102","article-title":"Innate immunity in Alzheimer's disease","volume":"16","author":"Heneka","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbi.2026.106796_b0120","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/glia.22892","article-title":"CCL11 enhances excitotoxic neuronal death by producing reactive oxygen species in microglia","volume":"63","author":"Parajuli","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2026.106796_b0125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbi.2020.09.006","article-title":"Relationships of inflammation trajectories with white matter volume and integrity in midlife","volume":"91","author":"O'Donovan","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2026.106796_b0130","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010-2050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2026.106796_b0135","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1001\/jama.2022.3550","article-title":"Association of Race and Ethnicity with Incidence of Dementia among older adults","volume":"327","author":"Kornblith","year":"2022","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.bbi.2026.106796_b0140","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1002\/alz.12962","article-title":"Sex differences in dementia risk and risk factors: Individual-participant data analysis using 21 cohorts across six continents from the COSMIC consortium","volume":"19","author":"Gong","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbi.2026.106796_b0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13293-022-00431-5","article-title":"Sex differences in the association between cardiovascular diseases and dementia subtypes: a prospective analysis of 464,616 UK Biobank participants","volume":"13","author":"Dong","year":"2022","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.bbi.2026.106796_b0150","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1016\/S2666-7568(24)00061-8","article-title":"Population attributable fractions of modifiable risk factors for dementia: a systematic review and meta-analysis","volume":"5","author":"Stephan","year":"2024","journal-title":"Lancet Healthy Longev."},{"key":"10.1016\/j.bbi.2026.106796_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102380","article-title":"A review of the literature on wellbeing and modifiable dementia risk factors","volume":"99","author":"Willroth","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbi.2026.106796_b0160","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bbi.2023.02.009","article-title":"Lung function and risk of incident dementia: a prospective cohort study of 431,834 individuals","volume":"109","author":"Ma","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2026.106796_b0165","doi-asserted-by":"crossref","first-page":"e574","DOI":"10.1212\/WNL.0000000000200853","article-title":"Nonalcoholic Fatty Liver Disease and risk of Dementia: a Population-based Cohort Study","volume":"99","author":"Shang","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2026.106796_b0170","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41581-025-00967-w","article-title":"Chronic kidney disease and dementia: an epidemiological perspective","volume":"21","author":"Ikram","year":"2025","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bbi.2026.106796_b0175","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s40263-016-0392-x","article-title":"Neurological and Neuropsychiatric adverse Effects of Dermatologic Medications","volume":"30","author":"Liu","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bbi.2026.106796_b0180","article-title":"Asthma amplifies dementia risk: Evidence from CSF biomarkers and cognitive decline","volume":"8","author":"Nair","year":"2022","journal-title":"Alzheimers Dement (n y)."},{"key":"10.1016\/j.bbi.2026.106796_b0185","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/all.14221","article-title":"Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. a systematic review for the EAACI guidelines - recommendations on the use of biologicals in severe asthma","volume":"75","author":"Agache","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.bbi.2026.106796_b0190","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/all.14235","article-title":"Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: a systematic review for the EAACI guidelines - recommendations on the use of biologicals in severe asthma","volume":"75","author":"Agache","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.bbi.2026.106796_b0195","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/jdv.18345","article-title":"European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy","volume":"36","author":"Wollenberg","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159126005441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159126005441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:39:49Z","timestamp":1793605189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159126005441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":39,"alternative-id":["S0889159126005441"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2026.106796","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced dementia risk in middle-aged and older atopic dermatitis patients treated with dupilumab: A target trial emulation","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2026.106796","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106796"}}